{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:01:48Z","timestamp":1784671308817,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M773578"],"award-info":[{"award-number":["2025M773578"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007956","name":"Nanjing University of Chinese Medicine","doi-asserted-by":"publisher","award":["ZYXJC2024-006"],"award-info":[{"award-number":["ZYXJC2024-006"]}],"id":[{"id":"10.13039\/501100007956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373710"],"award-info":[{"award-number":["82373710"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504578"],"award-info":[{"award-number":["82504578"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejmech.2026.118778","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:02:36Z","timestamp":1773421356000},"page":"118778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Fluorescence polarization\u2013based discovery of natural ROR\u03b3 orthosteric inhibitors"],"prefix":"10.1016","volume":"309","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9783-775X","authenticated-orcid":false,"given":"Yan-Cheng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Hao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Fan","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jiao","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Liang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1589-7442","authenticated-orcid":false,"given":"Nian-Guang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118778_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.immuni.2007.11.016","article-title":"T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma","volume":"28","author":"Yang","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.ejmech.2026.118778_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.12.007","article-title":"A cellular and molecular view of T helper 17 cell plasticity in autoimmunity","volume":"87","author":"Stadhouders","year":"2018","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejmech.2026.118778_bib3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1038\/s12276-025-01535-9","article-title":"Th17 cell pathogenicity in autoimmune disease","volume":"57","author":"Park","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118778_bib4","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1124\/mol.109.060905","article-title":"The benzenesulfoamide T0901317 [N-(2,2,2-trifluoroethyl)-N-[4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethy l]phenyl]-benzenesulfonamide] is a novel retinoic acid receptor-related orphan receptor-alpha\/gamma inverse agonist","volume":"77","author":"Kumar","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118778_bib5","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/cb3002649","article-title":"Identification of a selective ROR\u03b3 ligand that suppresses T(H)17 cells and stimulates T regulatory cells","volume":"7","author":"Solt","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118778_bib6","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1080\/17460441.2021.1948833","article-title":"Retinoic acid-related orphan receptor gamma t (ROR\u03b3t) inverse agonists\/antagonists for the treatment of inflammatory diseases - where are we presently?","volume":"16","author":"Gege","year":"2021","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.118778_bib7","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/bjd.16131","article-title":"A phase I randomized controlled trial to evaluate safety and clinical effect of topically applied GSK2981278 ointment in a psoriasis plaque test","volume":"178","author":"Kang","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejmech.2026.118778_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13543776.2017.1262350","article-title":"ROR\u03b3t inhibitors as potential back-ups for the phase II candidate VTP-43742 from vitae pharmaceuticals: patent evaluation of WO2016061160 and US20160122345","volume":"27","author":"Gege","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2026.118778_bib10","unstructured":"A Randomized, Double-Blind, Placebo-Controlled, Study to Assess the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AGN-242428 in Patients with Plaque Psoriasis. https:\/\/clinicaltrials.gov\/study\/NCT03339999 (accessed (NCT03339999)."},{"key":"10.1016\/j.ejmech.2026.118778_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/13543776.2019.1655541","article-title":"Retinoic acid receptor-related orphan receptor gamma-t (ROR\u03b3t) inhibitors in clinical development for the treatment of autoimmune diseases: a patent review (2016-present)","volume":"29","author":"Sun","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2026.118778_bib12","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acsmedchemlett.0c00063","article-title":"Discovery of BMS-986251: a clinically viable, potent, and selective ROR\u03b3t inverse agonist","volume":"11","author":"Cherney","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118778_bib14","first-page":"93","article-title":"Thymic lymphomas in a 6-Month rasH2-Tg mouse carcinogenicity study with the RORgammat inverse agonist, BMS-986251","volume":"183","author":"Haggerty","year":"2021","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejmech.2026.118778_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317090","article-title":"ROR\u03b3t inverse agonists demonstrating a margin between inhibition of IL-17A and thymocyte apoptosis","volume":"20","author":"Collins","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118778_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/JCI185942","article-title":"Selective disruption of ROR\u03b3t-CBF\u03b2 interaction by IMU-935 prevents ROR\u03b3t-dependent Th17 autoimmunity but not thymocyte development","volume":"136","author":"Wu","year":"2026","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.118778_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202502362","article-title":"Natural products for regulation of autoimmune diseases: chemical diversity, pharmacology, and therapeutic applications","author":"Sha","year":"2025","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.ejmech.2026.118778_bib18","doi-asserted-by":"crossref","first-page":"22707","DOI":"10.1074\/jbc.C111.250407","article-title":"Ursolic acid suppresses interleukin-17 (IL-17) production by selectively antagonizing the function of RORgamma t protein","volume":"286","author":"Xu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118778_bib19","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature09978","article-title":"Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORgammat activity","volume":"472","author":"Huh","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118778_bib20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1039\/D0NP00047G","article-title":"Natural products as modulators of retinoic acid receptor-related orphan receptors (RORs)","volume":"38","author":"Ladurner","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2026.118778_bib21","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021287118","article-title":"Cooperativity between the orthosteric and allosteric ligand binding sites of ROR\u03b3t","volume":"118","author":"de Vries","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118778_bib22","doi-asserted-by":"crossref","DOI":"10.1088\/2050-6120\/4\/2\/022001","article-title":"Fluorescence polarization assays in high-throughput screening and drug discovery: a review","volume":"4","author":"Hall","year":"2016","journal-title":"Methods Appl. Fluoresc."},{"key":"10.1016\/j.ejmech.2026.118778_bib23","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.drudis.2020.07.024","article-title":"High-throughput screening: today's biochemical and cell-based approaches","volume":"25","author":"Blay","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.118778_bib24","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/acs.jmedchem.4c00058","article-title":"Discovery of ROR\u03b3 allosteric fluorescent probes and their application: fluorescence polarization, screening, and bioimaging","volume":"67","author":"Yu","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118778_bib25","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nprot.2011.305","article-title":"Analysis of protein-ligand interactions by fluorescence polarization","volume":"6","author":"Rossi","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2026.118778_bib26","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1073\/pnas.69.6.1392","article-title":"Dynamics of fluorescence polarization in macromolecules","volume":"69","author":"Belford","year":"1972","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118778_bib27","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1016\/j.bmcl.2015.05.026","article-title":"Discovery of biaryl carboxylamides as potent RORgamma inverse agonists","volume":"25","author":"Chao","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.118778_bib28","series-title":"Biaryl-Containing Compounds as Inverse Agonists of ROR-gamma Receptors and their Preparation","author":"Chao","year":"2014"},{"key":"10.1016\/j.ejmech.2026.118778_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/ml1000382","article-title":"Discovery of potent and selective urea-based ROCK inhibitors and their effects on intraocular pressure in rats","volume":"1","author":"Yin","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118778_bib30","doi-asserted-by":"crossref","DOI":"10.1134\/S0006297911110101","article-title":"The molecular probes handbook. A guide to fluorescent probes and labeling technologies","volume":"76","author":"Wiederschain","year":"2011","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2026.118778_bib31","doi-asserted-by":"crossref","first-page":"12831","DOI":"10.1021\/acs.jmedchem.1c00882","article-title":"Strategies toward discovery of potent and orally bioavailable proteolysis targeting chimera degraders of androgen receptor for the treatment of prostate cancer","volume":"64","author":"Han","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118778_bib32","doi-asserted-by":"crossref","first-page":"13438","DOI":"10.1021\/jacs.6b09173","article-title":"Remarkable enhancement of chemiluminescent signal by Dioxetane-Fluorophore conjugates: turn-ON chemiluminescence probes with color modulation for sensing and imaging","volume":"138","author":"Hananya","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118778_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115871","article-title":"Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke","volume":"261","author":"Chen","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118778_bib34","doi-asserted-by":"crossref","first-page":"14199","DOI":"10.1039\/D0CC06353C","article-title":"A small-molecule probe for monitoring binding to prolyl hydroxylase domain 2 by fluorescence polarisation","volume":"56","author":"Li","year":"2020","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2026.118778_bib35","doi-asserted-by":"crossref","first-page":"28.29.14","DOI":"10.1002\/0471140864.ps2809s79","article-title":"Analysis of protein stability and ligand interactions by thermal shift assay","volume":"79","author":"Huynh","year":"2015","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.ejmech.2026.118778_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"Simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen"},{"key":"10.1016\/j.ejmech.2026.118778_bib37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nature10075","article-title":"Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand","volume":"472","author":"Solt","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118778_bib38","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/cb1002762","article-title":"Identification of SR3335 (ML-176): a synthetic RORalpha selective inverse agonist","volume":"6","author":"Kumar","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118778_bib39","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1038\/ncomms9833","article-title":"Identification of an allosteric binding site for RORgammat inhibition","volume":"6","author":"Scheepstra","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118778_bib40","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118778_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.32598\/bcn.2021.2252.1","article-title":"Evaluating the effects of Epigallocatechin-3-Gallate on HIF-1\u03b1 protein and RORC gene expression in peripheral blood mononuclear cells in patients with multiple sclerosis","volume":"12","author":"Afshar","year":"2021","journal-title":"Basic Clin. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118778_bib42","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.3892\/etm.2015.2824","article-title":"Epigallocatechin-3-gallate-induced inhibition of interleukin-6 release and adjustment of the regulatory T\/T helper 17 cell balance in the treatment of colitis in mice","volume":"10","author":"Xu","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejmech.2026.118778_bib43","first-page":"243","article-title":"Plant-based immunomodulators and their potential therapeutic actions","volume":"vol. 7","author":"Pathak","year":"2022","journal-title":"J. Explor. Res. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118778_bib44","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acsnano.2c08979","article-title":"Reactive oxygen species-responsive gel-based microneedle patches for prolonged and intelligent psoriasis management","volume":"17","author":"Bi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.118778_bib45","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbae122","article-title":"Curcumin-incorporated EGCG-based nano-antioxidants alleviate colon and kidney inflammation via antioxidant and anti-inflammatory therapy","volume":"11","author":"Pan","year":"2024","journal-title":"Regen. Biomater."},{"key":"10.1016\/j.ejmech.2026.118778_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.actbio.2022.06.039","article-title":"An injectable co-assembled hydrogel blocks reactive oxygen species and inflammation cycle resisting myocardial ischemia-reperfusion injury","volume":"149","author":"Liao","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejmech.2026.118778_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122509","article-title":"Injectable pathological microenvironment-responsive anti-inflammatory hydrogels for ameliorating intervertebral disc degeneration","volume":"306","author":"Liu","year":"2024","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2026.118778_bib48","article-title":"Self-propelled ultrasmall AuNPs-Tannic acid hybrid nanozyme with ROS-scavenging and anti-inflammatory activity for drug-induced liver injury alleviation","volume":"19","author":"Zhou","year":"2023","journal-title":"Small"},{"key":"10.1016\/j.ejmech.2026.118778_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123614","article-title":"An antioxidative injectable chitosan hydrogel based on tannic acid modified dialdehyde polyurethane nano-crosslinker targeting RIPK1 to regulate neuroinflammation for amelioration of Parkinson's disease","volume":"325","author":"Xu","year":"2026","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2026.118778_bib50","doi-asserted-by":"crossref","first-page":"33212","DOI":"10.1021\/acsnano.5c07601","article-title":"Tannic acid-iron complex-based nanozyme ameliorates parkinson's disease via relieving oxidative stress and neuroinflammation","volume":"19","author":"He","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.ejmech.2026.118778_bib51","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.1021\/acs.jmedchem.5c00390","article-title":"Identification of JNJ-61803534, a ROR\u03b3t inverse agonist for the treatment of psoriasis","volume":"68","author":"Kinzel","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118778_bib52","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1021\/acs.jmedchem.3c01933","article-title":"Discovery and SAR of JTE-151: a novel ROR\u03b3 inhibitor for clinical development","volume":"67","author":"Maeba","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118778_bib53","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2026.118778_bib54","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1021\/acs.jmedchem.1c02058","article-title":"Discovery and structural optimization of toddacoumalone derivatives as novel PDE4 inhibitors for the topical treatment of psoriasis","volume":"65","author":"Song","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118778_bib55","doi-asserted-by":"crossref","first-page":"13807","DOI":"10.1021\/acs.jmedchem.1c01197","article-title":"AZD0284, a potent, selective, and orally bioavailable inverse agonist of retinoic acid receptor-related orphan receptor C2","volume":"64","author":"Narjes","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T21:17:01Z","timestamp":1784668621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426002230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":53,"alternative-id":["S0223523426002230"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118778","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluorescence polarization\u2013based discovery of natural ROR\u03b3 orthosteric inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118778","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118778"}}